A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 ...

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

Lung cancer has traditionally been associated with advanced age; however, its increasing incidence among young adults raises concerning questions regarding its etiology and unique considerations for ...

During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...

A study led by Dana-Farber Cancer Institute researchers found that combining chemotherapy and immunotherapy before surgery for patients with aggressive stage III non-small cell lung cancer that is ...

As attorneys try to free a 6-year-old boy treated for cancer, as well as his mother and sibling, they're challenging the Trump administration’s immigration court arrests.

Key Statistics for Rhabdomyosarcoma Learn about key statistics for rhabdomyosarcoma (RMS), including how common it is, who is most affected, and the outlook for those with a diagnosis.

Intas and its subsidiary Accord Healthcare lead commercialisation in Europe and India. In December 2022, serplulimab received orphan drug designation from the EC for the treatment of SCLC, this ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

Loss of the tumor suppressor KEAP1 drives chemoresistance in SCLC—but also reveals a surprising metabolic weakness that may offer a new therapeutic option.

ON THIS PAGEBrain MetastasisSigns and SymptomsDiagnosisTreatmentPrognosis and OutlookLung cancer is one of the kinds of cancer that is most likely to spread to the brain. Approximately 20 percent of ...